Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

November 30, 2026

Conditions
Bell's PalsyRamsay Hunt SyndromeLyme DiseaseFacial Palsy
Interventions
DEVICE

BlinkER device.

Participants will use the BlinkER System for 8-16 hours daily (removed during sleep) at approximately 10 blinks/minute. The stimulation cycle will be ON and OFF to achieve the desired blink rate. Participants will receive training on device usage before starting the study.

Trial Locations (1)

33064

Rand Eye Institute, Deerfield Beach

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neurotrigger Ltd

INDUSTRY

NCT06542289 - Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy | Biotech Hunter | Biotech Hunter